Established in 2003, Clinogent is the Clinical Research & Development business unit of GVK BIO. A full service CRO, Clinogent offers a suite of Clinical Pharmacology and Clinical Research services to support Innovator & Generic Pharmaceutical and Biotech organizations globally.
Clinogent is an internationally reputed service provider and has one of the largest state-of-the-art facilities in India inspected by DCGI, USFDA, ANSM, WHO, MHRA, ANVISA & MoH Turkey, thereby crediting it with global submission footprint.
Housed in a lab space of 140,000 sq.ft, Clinogent has seven independent clinics with 254 beds. Clinogent hosts a scientific pool of 300 scientists, Senior Leadership team with around 15 – 20 years in Clinical development, >275 clinical investigators and over 35000 volunteer databases. Clinogent has successfully handled 1000+ bio studies and >350,000 bio-analytical samples per year.
Clinogent is a preferred partner of the Bill & Melinda Gates Foundation and CSIR for Clinical Research Services. It has the distinction of being a CRO with the most extensive Vaccines experience in India (17 trials-India and Bangladesh). Currently the team have worked on 80+ projects across >14 therapeutic areas in the last 10 years, having monitoring sites across India, Bangladesh and Nepal.
Company Details
Clinogent Questions
Clinogent's LinkedIn profile is https://in.linkedin.com/company/clinogent
Clinogent has
4 employees.
View email and phone details for 4
employees at Clinogent.
Clinogent's industry is
Biotechnology Research
Clinogent's top competitors are
Clinigene,
Clinipace,
Nilo Medical Consulting Group,
Corcoran Consulting Group,
Parexel,
Karmic Lifesciences Llp,
Sanofi,
Pearl Chemist Group,
Aragen Life Sciences,
Clinsync Clinical Research Pvt Ltd.
Clinogent's categories are Biotechnology Research
Clinogent's founding year is 2003
